Table 4 Concurrence of malignant tumors and anti-GABA-B receptor encephalitis
Group | Favorable-prognosis group (n = 11) | Poor-prognosis group (n = 8) | Total (n = 19) |
|---|---|---|---|
Accompanied malignant tumor | 1 (9.1%) | 5 (62.5%) | 6 (31.6%) |
No malignant tumor | 10 (90.9%) | 3 (37.5%) | 13 (68.4%) |
Total | 11 (100%%) | 8 (100%) | 19 (100%) |